[go: up one dir, main page]

DK0621862T3 - Organiske salte af N,N-diacetylcystin - Google Patents

Organiske salte af N,N-diacetylcystin

Info

Publication number
DK0621862T3
DK0621862T3 DK92924975.3T DK92924975T DK0621862T3 DK 0621862 T3 DK0621862 T3 DK 0621862T3 DK 92924975 T DK92924975 T DK 92924975T DK 0621862 T3 DK0621862 T3 DK 0621862T3
Authority
DK
Denmark
Prior art keywords
diacetylcystine
organic salts
salts
organic
Prior art date
Application number
DK92924975.3T
Other languages
Danish (da)
English (en)
Inventor
Edib Jakupovic
Carl-Magnus Andersson
Hakan Bergstrand
Bo-Goeran Josefsson
Magnus Lindvall
Bengt Saernstrand
Eric Teneberg
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Application granted granted Critical
Publication of DK0621862T3 publication Critical patent/DK0621862T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/22—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of hydropolysulfides or polysulfides
    • C07C319/24—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of hydropolysulfides or polysulfides by reactions involving the formation of sulfur-to-sulfur bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/57—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C323/58—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
    • C07C323/59—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton with acylated amino groups bound to the carbon skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK92924975.3T 1991-11-29 1992-11-25 Organiske salte af N,N-diacetylcystin DK0621862T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9103572A SE9103572D0 (sv) 1991-11-29 1991-11-29 Organic salts of n,n'-diacetyl cystine

Publications (1)

Publication Number Publication Date
DK0621862T3 true DK0621862T3 (da) 1996-09-16

Family

ID=20384494

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92924975.3T DK0621862T3 (da) 1991-11-29 1992-11-25 Organiske salte af N,N-diacetylcystin

Country Status (38)

Country Link
US (5) US5385904A (fr)
EP (1) EP0621862B1 (fr)
JP (1) JP3302018B2 (fr)
KR (1) KR100256185B1 (fr)
CN (1) CN1039586C (fr)
AP (1) AP350A (fr)
AT (1) ATE141913T1 (fr)
AU (1) AU657827B2 (fr)
CA (1) CA2123516A1 (fr)
CZ (1) CZ282085B6 (fr)
DE (1) DE69213256T2 (fr)
DK (1) DK0621862T3 (fr)
DZ (1) DZ1637A1 (fr)
EE (1) EE03025B1 (fr)
ES (1) ES2090713T3 (fr)
FI (1) FI942504A7 (fr)
GR (1) GR3021546T3 (fr)
HK (1) HK62297A (fr)
HR (1) HRP921322B1 (fr)
HU (1) HU215390B (fr)
IL (1) IL103778A (fr)
IS (1) IS1645B (fr)
LV (1) LV11949B (fr)
MA (1) MA22716A1 (fr)
MX (1) MX9206851A (fr)
MY (1) MY110523A (fr)
NO (1) NO301325B1 (fr)
NZ (1) NZ245077A (fr)
PL (2) PL171336B1 (fr)
RU (1) RU2135468C1 (fr)
SE (1) SE9103572D0 (fr)
SG (1) SG73962A1 (fr)
SI (1) SI9200351A (fr)
SK (1) SK281697B6 (fr)
TN (1) TNSN92108A1 (fr)
WO (1) WO1993011104A1 (fr)
YU (1) YU48594B (fr)
ZA (1) ZA928739B (fr)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3865463A (en) * 1973-11-12 1975-02-11 Busch & Co Inc Ag Electrical adapter plug
DK0494405T3 (da) * 1991-01-10 1996-11-18 Transcend Therapeutics Inc Anvendelse af thiazolidin-4-carboxylatderivater til behandling af lungesygdomme
US5747459A (en) * 1991-02-04 1998-05-05 Nestec, Ltd. Method for insuring adequate intracellular glutathione in tissue
US5430045A (en) * 1992-04-23 1995-07-04 Free Radical Sciences, Inc. Method of reducing or preventing bone marrow hypoplasia
US5447712A (en) * 1993-12-09 1995-09-05 Free Radical Sciences Method of reducing cyclophosphamide induced hemorrhagic cystitis
SE9500897D0 (sv) * 1995-03-14 1995-03-14 Astra Ab The pharmacological use of certain cystine derivatives
SE9602262D0 (sv) * 1996-06-06 1996-06-06 Astra Ab New use of derivatives of cystine
US6017959A (en) * 1996-06-18 2000-01-25 Astra Aktiebolag Forms of organic salts of N,N'-diacetylcystine
AR007398A1 (es) * 1996-06-18 1999-10-27 Astrazeneca Ab Proceso para preparar sales inorganicas de n-n'-diacetilcistina
SE9602416D0 (sv) * 1996-06-18 1996-06-18 Astra Ab New forms of an organic salt of N'N-diacetylcystine
CN1059907C (zh) * 1997-05-23 2000-12-27 中国石油化工集团公司巴陵石化岳阳石油化工总厂 一种含共轭二烯轻聚合物的选择氢化方法
US20030203006A1 (en) * 1997-10-29 2003-10-30 Ajinomoto Co. Inc. Immunomodulator
US6197749B1 (en) * 1997-10-29 2001-03-06 Ajinomoto Co., Inc. Method of suppressing immune responses by reducing intracellular content of glutathione in macrophages and monocytes
SE9800932D0 (sv) * 1998-03-20 1998-03-20 Astra Ab New compunds
EP1004302A3 (fr) * 1998-10-29 2003-06-04 Ajinomoto Co., Inc. Immunomodulateur
SE9900438D0 (sv) * 1999-02-10 1999-02-10 Astra Ab The pharmacological use of certian cystine derivatives
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
NO20003591L (no) * 2000-07-13 2002-01-14 Thia Medica As Fettsyreanaloger for behandling av kreft
SE518784C2 (sv) * 2000-12-27 2002-11-19 Nactilus Ab "N-Acetyl-L-cystein med kompositioner för behandling av neoplasier"
US20040156802A1 (en) * 2001-03-13 2004-08-12 Keiji Iwasaki Cosmetics or external preparations for skin
RU2317299C2 (ru) * 2001-08-10 2008-02-20 Кабусики Кайся Хаясибара Сеибуцу Кагаку Ассоциат, содержащий трегалозу и хлорид кальция, в форме кристаллического моногидрата или безводного кристалла
ES2425392T3 (es) 2002-03-20 2013-10-15 Mannkind Corporation Cartucho para un aparato de inhalación
ES2363001T3 (es) * 2003-03-11 2011-07-18 Pharmacia Corporation Sal cristalina de clorhidrato de maleato de s-[2(1-iminoetil)etil]-2-metil-l-cisteina.
DK1786784T3 (da) 2004-08-20 2011-02-14 Mannkind Corp Katalyse af diketopiperazinsyntese
BR122019022692B1 (pt) 2004-08-23 2023-01-10 Mannkind Corporation Composição terapêutica em pó seco contendo dicetopiperazina, pelo menos um tipo de cátion e um agente biologicamente ativo
WO2007033372A2 (fr) 2005-09-14 2007-03-22 Mannkind Corporation Procede de preparation de medicaments fonde sur l'accroissement de l'affinite des surfaces de microparticules cristallines pour des principes actifs
DK1986679T3 (da) 2006-02-22 2017-11-20 Mannkind Corp Fremgangsmåde til forbedring af mikropartiklers farmaceutiske egenskaber omfattende diketopiperazin og et aktivt indholdsstof
US8438729B2 (en) * 2006-03-09 2013-05-14 Canon Kabushiki Kaisha Method of producing liquid discharge head
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
CA3153292A1 (fr) 2008-06-13 2009-12-17 Mannkind Corporation Inhalateur de poudre seche et systeme d'administration de medicament
CN102065942B (zh) 2008-06-20 2013-12-11 曼金德公司 用于对吸入工作进行实时描绘的交互式设备和方法
TWI532497B (zh) 2008-08-11 2016-05-11 曼凱公司 超快起作用胰島素之用途
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
PL2405963T3 (pl) 2009-03-11 2014-04-30 Mannkind Corp Urządzenie, układ i sposób pomiaru oporu inhalatora
KR20180036807A (ko) 2009-06-12 2018-04-09 맨카인드 코포레이션 한정된 비표면적을 갖는 디케토피페라진 마이크로입자
CA2778698A1 (fr) 2009-11-03 2011-05-12 Mannkind Corporation Appareil et methode de simulation d'efforts d'inhalation
RU2571331C1 (ru) 2010-06-21 2015-12-20 Маннкайнд Корпорейшн Системы и способы доставки сухих порошковых лекарств
KR101940832B1 (ko) 2011-04-01 2019-01-21 맨카인드 코포레이션 의약 카트리지용 블리스터 패키지
WO2012174472A1 (fr) 2011-06-17 2012-12-20 Mannkind Corporation Microparticules de dicétopipérazine de capacité élevée
EP2776053A1 (fr) 2011-10-24 2014-09-17 MannKind Corporation Procédés et compositions pour traiter la douleur
CN102491926B (zh) * 2011-12-15 2013-09-25 青岛市药品检验所 一种硫普罗宁二硫化物的制备和纯化方法
CN104619369B (zh) 2012-07-12 2018-01-30 曼金德公司 干粉药物输送系统和方法
EP2911690A1 (fr) 2012-10-26 2015-09-02 MannKind Corporation Compositions et procédés de vaccin antigrippal inhalable
AU2014228415B2 (en) 2013-03-15 2018-08-09 Mannkind Corporation Microcrystalline diketopiperazine compositions and methods
CA2918369C (fr) 2013-07-18 2021-06-29 Mannkind Corporation Compositions pharmaceutiques en poudre seche stables a la chaleur et procedes
WO2015021064A1 (fr) 2013-08-05 2015-02-12 Mannkind Corporation Appareil d'insufflation et procédés
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
US20230157939A1 (en) * 2020-04-28 2023-05-25 Conopco, Inc., D/B/A Unilever Personal care compositions with enhanced solubility actives
EP4216939A4 (fr) * 2020-09-28 2024-10-23 Georgia Tech Research Corporation Utilisation de cystéine et de ses dérivés comme agents anti-thrombotiques et thrombolytiques

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB592631A (en) * 1945-04-04 1947-09-24 Du Pont Cysteine and cystine
GB954268A (en) 1962-02-26 1964-04-02 Mead Johnson & Co Decongestant compositions comprising n-acylated sulphydryl compounds
FR8205M (fr) * 1968-12-20 1970-09-14
US3647834A (en) 1969-08-11 1972-03-07 Mead Johnson & Co Zinc mercaptide n-acetylcysteine carboxylate salts
US3878305A (en) * 1972-05-25 1975-04-15 Procter & Gamble Fortification of foodstuffs with n-acyl derivatives of sulphur-containing l-amino acids
US3952115A (en) * 1975-04-02 1976-04-20 The Procter & Gamble Company Fortification of foodstuffs with N-acyl derivatives of sulfur-containing L-amino acid esters
US4141734A (en) * 1975-09-11 1979-02-27 Ciba-Geiby Ag Photographic developing process
US4093739A (en) * 1977-06-15 1978-06-06 Mead Johnson & Company Mercaptoacylamidobenzoyl glycine and mucolytic process
JPS6011888B2 (ja) * 1978-10-11 1985-03-28 参天製薬株式会社 リウマチ疾患治療薬
JPS56155298A (en) 1980-05-02 1981-12-01 Tanabe Seiyaku Co Shampoo composition
FR2503151A1 (fr) * 1981-04-02 1982-10-08 Morelle Jean Butyryminoacides soufres. mode de preparation. emploi comme element keratogenique chez l'homme et l'animal et comme agent de fertilisation chez les vegetaux
GB2097256B (en) * 1981-04-02 1985-05-30 Morelle Jean V Compositions containing n-butyryl alphaaminoacids
JPS58164566A (ja) * 1982-03-09 1983-09-29 Kenji Okawa シスチン類の製造法
US4827016A (en) * 1985-09-16 1989-05-02 Morgan Lee R Method and compounds for reducing dermal inflammations
US4724239A (en) * 1985-09-16 1988-02-09 Morgan Lee R Method of treating chemical ulcers with N,N'-diacetylcystine, N-acetyl homocysteine and N-acetyl cysteine
US4708965A (en) 1985-09-16 1987-11-24 Morgan Lee R Method of treating herpes virus infections with N,N'-diacetylcystine and derivatives
JPH0660157B2 (ja) * 1985-11-20 1994-08-10 三井東圧化学株式会社 システインからシスチンを製造する方法
JPS62195356A (ja) * 1986-02-20 1987-08-28 Seiwa Kasei:Kk シスチン誘導体及びその塩
AT402931B (de) * 1986-11-07 1997-09-25 Pharmacia Gmbh Verfahren zur herstellung von neuen cystinverbindungen und derenverwendung
SE8704542D0 (sv) * 1987-11-19 1987-11-19 Draco Ab New derivatives of cysteine
IL98310A (en) * 1990-06-08 1996-08-04 Astra Ab Pharmaceutical compositions comprising cystine derivatives
TW221376B (fr) * 1990-06-28 1994-03-01 Astra Ab
GB9111885D0 (en) * 1991-06-03 1991-07-24 Erba Carlo Spa Nerve growth factor for use in the prevention and treatment of viral infections

Also Published As

Publication number Publication date
EP0621862B1 (fr) 1996-08-28
KR100256185B1 (ko) 2000-05-15
AP350A (en) 1994-08-09
SI9200351A (en) 1993-06-30
ZA928739B (en) 1993-06-09
LV11949B (en) 1998-07-20
NO941968D0 (no) 1994-05-26
FI942504A0 (fi) 1994-05-27
RU2135468C1 (ru) 1999-08-27
LV11949A (lv) 1998-01-20
AP9200448A0 (en) 1993-01-31
PL171336B1 (en) 1997-04-30
US5385904A (en) 1995-01-31
US5824681A (en) 1998-10-20
IL103778A0 (en) 1993-04-04
US5650538A (en) 1997-07-22
HUT70851A (en) 1995-11-28
WO1993011104A1 (fr) 1993-06-10
AU3099692A (en) 1993-06-28
NO941968L (no) 1994-05-26
DZ1637A1 (fr) 2002-02-17
DE69213256D1 (de) 1996-10-02
MY110523A (en) 1998-07-31
EP0621862A1 (fr) 1994-11-02
ES2090713T3 (es) 1996-10-16
CZ282085B6 (cs) 1997-05-14
HK62297A (en) 1997-05-16
HRP921322B1 (en) 1998-12-31
IS3949A (is) 1993-05-30
EE03025B1 (et) 1997-08-15
HU215390B (hu) 1998-12-28
MX9206851A (es) 1993-05-01
CZ129794A3 (en) 1995-01-18
ATE141913T1 (de) 1996-09-15
NZ245077A (en) 1995-04-27
FI942504L (fi) 1994-05-27
HU9401473D0 (en) 1994-08-29
GR3021546T3 (en) 1997-02-28
CA2123516A1 (fr) 1993-06-10
MA22716A1 (fr) 1993-07-01
PL170787B1 (en) 1997-01-31
TNSN92108A1 (fr) 1993-06-08
FI942504A7 (fi) 1994-05-27
DE69213256T2 (de) 1997-01-23
AU657827B2 (en) 1995-03-23
SE9103572D0 (sv) 1991-11-29
NO301325B1 (no) 1997-10-13
IL103778A (en) 1997-08-14
SK281697B6 (sk) 2001-06-11
SG73962A1 (en) 2000-07-18
JPH07501539A (ja) 1995-02-16
CN1073683A (zh) 1993-06-30
US5804582A (en) 1998-09-08
JP3302018B2 (ja) 2002-07-15
IS1645B (is) 1997-03-25
YU48594B (sh) 1998-12-23
YU99092A (sh) 1995-12-04
HRP921322A2 (en) 1996-10-31
US5693858A (en) 1997-12-02
SK63294A3 (en) 1995-02-08
CN1039586C (zh) 1998-08-26

Similar Documents

Publication Publication Date Title
DK0621862T3 (da) Organiske salte af N,N-diacetylcystin
FI934919A0 (fi) Avgivningssystem med kontrollerad, foerlaengd frigivning foer roekavvaenjning
MX9205145A (es) Nuevos derivados heterociclicos.
FI921708L (fi) Stolstoppning, speciellt flygplansfaotoelj
FI925721L (fi) Transportabel medicinsk anordning, saerskild infusionsbehandlingsapparat
FI922494L (fi) Pulverformig, enzymer innehaollande diskmedelskomposition foer automatiska diskmaskiner
DE59100656D1 (de) Bohrfutter.
DE59101925D1 (de) Bohrfutter.
FI922234L (fi) Kompositioner med laog loeslighet, vilka utgoers av paerlor belagda med laekemedel
DE69101171D1 (de) Laserbohren.
FI915825L (fi) Heterocykliska foereningar.
FI922451L (fi) Vaermehaerdande, pulveraktig belaeggningskomposition
FI934728L (fi) Stabila, enkomponent, haerdbara epoxi/polyamidhartsdispersioner
FI921926A7 (fi) Pesticida 1-aryl-5-(substituerade alkylidenimino)pyrazoler
FI922875L (fi) Foereningar med reninhaemmande egenskaper, foerfarande foer deras framstaellning och deras anvaendning
FI910750A7 (fi) Heterocykliska foereningar.
FI910572A7 (fi) Regnmaetare med anordning som paovisar tilltaeppning.
FI912220A7 (fi) Heterocykliska foereningar.
FI914910L (fi) Heterocykliska foereningar.
FI923367L (fi) Molekyler med antikroppkombinations- staellen som katalyserar hydrolysreaktioner.
FI922654L (fi) Saekringsanordning foer avtryckarmekanismer, isynnerhet foer eldvapen
FI925047A7 (fi) Tangentell slipmaskin, i synnerhet foer jaernvaegsskenor
DE69010184D1 (de) Naphthotriazoliumsalze.
FI912127A7 (fi) Effektivt delar utnyttjande, minnesbaserad funktionskrets med väljbara transmissionsegenskaper
FI925411A0 (fi) Fartyg, speciellt handelsfartyg